Doctors can view earlier CT scans beside live images during heart procedures with Philips' tool.
Philips (NYSE: PHG, AEX: PHIA) launched UniGuide 3D Live Guidance in Europe, integrating CT scan data into live heart procedures via its Azurion platform. The tool aims to improve treatment decisions by combining pre-procedural planning with real-time imaging, supporting PCI, structural heart, and vascular procedures. UniGuide is CE-marked and available in select markets from October 23, 2026, but not in the U.S.
How this was made
The 30-second read
Why it matters
The launch introduces CT‑derived guidance into live procedures, a first for the Azurion platform.
Market read
Product launch news with modest trading relevance for PHG; limited immediate price impact.
What to watch
Competition from other imaging vendors and the need for hospitals to upgrade existing Azurion systems.
Background
Philips is a global health‑technology company expanding its interventional imaging portfolio.
Ticker impact
Philips announced the launch of its new UniGuide 3D Live Guidance solution, a CE‑marked product integrated with the Azurion platform.
modest upside as hospitals may adopt the new workflow integration
First‑time disclosure of a new CE‑marked device; impact depends on adoption rates, so only limited short‑term price pressure.
Market effects
May strengthen the medical imaging and interventional equipment sector by adding a differentiated workflow solution.
Primarily Europe and other CE‑marked markets; no immediate US market effect.
Limited to healthcare equipment investors; unlikely to move broader indices.
Counterpoint
Adoption could be slower than expected if hospitals face budget constraints, limiting upside.
Key entities
- companyRoyal Philips
US‑listed health‑technology firm (NYSE: PHG) launching UniGuide 3D Live Guidance.


